<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04600804</url>
  </required_header>
  <id_info>
    <org_study_id>FIL_MCL0208-PET</org_study_id>
    <nct_id>NCT04600804</nct_id>
  </id_info>
  <brief_title>The Role of 18F-FDG-PET for Staging and Prognostication</brief_title>
  <official_title>The Role of 18F-FDG-PET for Staging and Prognostication in Patients Enrolled in the Fondazione Italiana Linfomi (FIL) MCL0208 Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Italiana Linfomi ONLUS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Italiana Linfomi ONLUS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective, multicenter, non-interventional, imaging study ancillary to FIL_MCL0208&#xD;
      clinical trial (NCT02354313) in untreated adult patients with mantle cell lymphoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective, multicenter, non-interventional, imaging study devoted to patients&#xD;
      diagnosed with MCL and enrolled in the MCL0208 international randomized, phase III clinical&#xD;
      trial (NCT02354313).&#xD;
&#xD;
      The study is aimed at addressing a number of prognostic issues that still need to be&#xD;
      clarified in MCL patients, by taking advantage of the PET performed within the MCL0208 trial&#xD;
      and available for the analysis, and the clinical records and molecular data generated in the&#xD;
      context of the trial.&#xD;
&#xD;
      In the clinical trial PET was optional at baseline (b-PET), before ASCT (i-PET) and&#xD;
      after-ASCT (eot-PET), and none of the exams was used in the decisionmaking strategy. All the&#xD;
      PETs available will be collected and considered for analysis. The study will not require&#xD;
      additional treatment or procedures except those required for the MCL0208 trial. The&#xD;
      participation of the patient to the MCL0208 trial is a pre-requisite to be involved in this&#xD;
      study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2020</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity (proportion) and agreement (Cohen K) of PET results (performed in different time points) compared to the current standard (TC plus bone marrow biopsy).</measure>
    <time_frame>24 months</time_frame>
    <description>To better define the role of PET for the staging of MCL patients at the time of diagnosis, for evaluation of response after induction treatment (pre-ASCT; i-PET) and post ASCT (eot-PET) in comparison to the current standards, namely computed axial tomography (CT) and bone marrow biopsy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-index, estimated comparing models adding or not PET parameters to standard prognostic factors in predicting PFS.</measure>
    <time_frame>24months</time_frame>
    <description>To build a new prognostic model for PFS, including PET parameters, MIPI-b and biological data (e.g. MRD, GEP and mutational parameters).The achievement of these objectives could help to plan futures studies in order to improve the outcome of MCL patients.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mantle Cell Lymphoma</condition>
  <arm_group>
    <arm_group_label>All patients registered in the MCL0208 trial</arm_group_label>
    <description>About 200 patients enrolled in the MCL0208 trial who performed the PET exams within the clinical trial and who consent to the present study: all PETs available at each center participating in this study will be collected and analyzed.&#xD;
In the clinical trial PET was optional at baseline (b-PET), before ASCT (i-PET) and after- ASCT (eot-PET). All the PETs available per patient will be collected and considered for analysis, both in the case PET are available at all the 3 time points above listed and in case of availability of PET at 1 or 2 time points only.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 300 patients have been enrolled in the MCL0208 trial. We expect to analyze the&#xD;
        PETs, clinical and biological data of about 200 patients enrolled in the MCL0208 trial who&#xD;
        performed the PET exams within the clinical trial and who consent to the present study: all&#xD;
        PETs available at each center participating in this study will be collected and analyzed.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Enrollment of the patient in the MCL0208 clinical trial documented by the signature of&#xD;
             the study informed consent;&#xD;
&#xD;
          -  Patient's treatment in one of the centers that participated in the MCL0208 trial and&#xD;
             that has joined the MCL0208-PET study as well;&#xD;
&#xD;
          -  Evidence of signed informed consent for the MCL0208-PET study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Mian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ematologia e Centro Trapianto Midollo Osseo, Ospedale di Bolzano, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Uffici Studi FIL</last_name>
    <phone>0039 0131 033151</phone>
    <email>segreteria@filinf.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Start-up FIL</last_name>
    <phone>0039 0131 033153</phone>
    <email>startup@filinf.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ematologia Grande Ospedale Metropolitano Bianchi Melacrino Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <state>Calabria</state>
        <zip>89124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caterina Stelitano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UO Ematologia e CTMO AOU di Parma</name>
      <address>
        <city>Parma</city>
        <state>Emilia Romagna</state>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesca Re, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O.Ematologia Ospedale Guglielmo da Saliceto</name>
      <address>
        <city>Piacenza</city>
        <state>Emilia Romagna</state>
        <zip>29121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Annalisa Arcari, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Ospedale delle Croci</name>
      <address>
        <city>Ravenna</city>
        <state>Emilia Romagna</state>
        <zip>48121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica Tani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Azienda Unit–∞ Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <state>Emilia Romagna</state>
        <zip>42123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Merli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. di Ematologia Ospedale degli Infermi di Rimini</name>
      <address>
        <city>Rimini</city>
        <state>Emilia Romagna</state>
        <zip>47923</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Lia Molinari, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.O.C. Oncologia Medica A Centro Riferimento Oncologico</name>
      <address>
        <city>Aviano</city>
        <state>Friuli Venezia Giulia</state>
        <zip>33081</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Grazia Michieli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SOC Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale (ASU FC)</name>
      <address>
        <city>Udine</city>
        <state>Friuli Venezia Giulia</state>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefano Volpetti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Universit–∞ Cattolica S. Cuore</name>
      <address>
        <city>Roma</city>
        <state>Latium</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan Hohaus, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l Oncologia</name>
      <address>
        <city>Genova</city>
        <state>Liguria</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chiara Ghiggi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. Clinica Ematologica Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l Oncologia</name>
      <address>
        <city>Genova</city>
        <state>Liguria</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ematologia Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luca Baldini, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SC Ematologia ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vittorio Ruggero Zilioli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia ASST MONZA Ospedale S. Gerardo</name>
      <address>
        <city>Monza</city>
        <state>Lombardia</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivana Casaroli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Div. di Ematologia IRCCS Policlinico S. Matteo di Pavia</name>
      <address>
        <city>Pavia</city>
        <state>Lombardia</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>U.O. Ematologia Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <state>Lombardia</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ematologia ASST Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <state>Lombardy</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.C. Ematologia A.O. SS. Antonio e Biagio e Cesare Arrigo</name>
      <address>
        <city>Alessandria</city>
        <state>Piedmont</state>
        <zip>15121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.C. di Ematologia e Trapianto di Midollo Osseo A.O. S. Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <state>Piedmont</state>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia Castellino, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCDU Ematologia AOU Maggiore della Carit–∞ di Novara</name>
      <address>
        <city>Novara</city>
        <state>Piedmont</state>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gianluca Gaidano, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Universitaria A.O.U. Citta della Salute e della Scienza di Torino</name>
      <address>
        <city>Turin</city>
        <state>Piedmont</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Federica Cavallo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.C.Ematologia A.O.U. Citta della Salute e della Scienza di Torino</name>
      <address>
        <city>Turin</city>
        <state>Piedmont</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carola Boccomini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ematologia Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <state>Puglia</state>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Di Renzo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O.C Ematologia e Trapianto A.O. C. Panico</name>
      <address>
        <city>Tricase</city>
        <state>Puglia</state>
        <zip>73039</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincenzo Pavone, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SC Ematologia e CTMO Ospedale Businco</name>
      <address>
        <city>Cagliari</city>
        <state>Sardinia</state>
        <zip>09121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>U.O.C. Ematologia e CTMO P.O. San Francesco</name>
      <address>
        <city>Nuoro</city>
        <state>Sardinia</state>
        <zip>08100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gianluca Doa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.C. Ematologia Azienda Ospedali Riuniti Papardo-Piemonte</name>
      <address>
        <city>Messina</city>
        <state>Sicily</state>
        <zip>98158</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donato Mannina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Divisione di Ematologia A.O. Ospedali Riuniti Villa Sofia-Cervello</name>
      <address>
        <city>Palermo</city>
        <state>Sicily</state>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Divisione di Ematologia e T.M.O. - Ospedale Centrale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <state>Trentino Alto Adige</state>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Unit–∞ funzionale di Ematologia Azienda Ospedaliera Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <state>Tuscany</state>
        <zip>50141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedetta Puccini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.C. Oncoematologia A.O. S. Maria di Terni</name>
      <address>
        <city>Terni</city>
        <state>Umbria</state>
        <zip>05100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Marina Liberati, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.C di Ematologia Ospedale Ca Foncello</name>
      <address>
        <city>Treviso</city>
        <state>Veneto</state>
        <zip>31100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piero Maria Stefani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. Ematologia AOU Integrata di Verona</name>
      <address>
        <city>Verona</city>
        <state>Veneto</state>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2020</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prognostic issues</keyword>
  <keyword>PET review</keyword>
  <keyword>MCL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma, Mantle-Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

